Grifols, S.A. is a global healthcare company founded in 1909, dedicated to improving the health and well-being of people worldwide. As a leader in plasma-derived medicines and transfusion medicine, Grifols develops, produces, and markets innovative medicines, solutions, and services across more than 110 countries and regions. With a workforce of over 20,000 employees, Grifols is committed to enhancing the lives of millions through its advanced healthcare solutions.